Summary of the Food and Drug Administration's Circulatory System Devices Advisory Panel meeting December 7 and 8, 2006, Gaithersburg, MD.
作者信息
Coons Kathryn C
机构信息
Division of Cardiology, Washington Hospital Center, Washington, DC 20010, USA.
出版信息
Cardiovasc Revasc Med. 2007 Jan-Mar;8(1):2-4. doi: 10.1016/j.carrev.2007.01.001.
PMID:17293261
Abstract
摘要
相似文献
1
Summary of the Food and Drug Administration's Circulatory System Devices Advisory Panel meeting December 7 and 8, 2006, Gaithersburg, MD.美国食品药品监督管理局循环系统器械咨询小组会议总结，2006年12月7日和8日，马里兰州盖瑟斯堡
Cardiovasc Revasc Med. 2007 Jan-Mar;8(1):2-4. doi: 10.1016/j.carrev.2007.01.001.
2
Stent thrombosis redux--the FDA perspective.支架内血栓复发——美国食品药品监督管理局的观点
N Engl J Med. 2007 Mar 8;356(10):984-7. doi: 10.1056/NEJMp068304. Epub 2007 Feb 12.
3
Unanswered questions--drug-eluting stents and the risk of late thrombosis.未解决的问题——药物洗脱支架与晚期血栓形成风险
N Engl J Med. 2007 Mar 8;356(10):981-4. doi: 10.1056/NEJMp068305. Epub 2007 Feb 12.
4
Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel meeting on the ACCULINK and ACCUNET Carotid Artery Stent System.2011年美国食品药品监督管理局循环系统器械专家小组关于ACCULINK和ACCUNET颈动脉支架系统会议概述。
Circulation. 2012 May 8;125(18):2256-64. doi: 10.1161/CIRCULATIONAHA.111.073486.
5
Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006.冠状动脉药物洗脱支架中的血栓形成：来自食品药品监督管理局器械与放射健康中心循环系统医疗器械咨询小组2006年12月7 - 8日会议的报告
Circulation. 2007 May 1;115(17):2352-7. doi: 10.1161/CIRCULATIONAHA.107.688416.
6
Debating the risks of drug-eluting stents.讨论药物洗脱支架的风险。
N Engl J Med. 2007 Jan 25;356(4):325-8. doi: 10.1056/NEJMp068300.
7
Overview of the 2011 food and drug administration's circulatory system devices panel of the medical devices advisory committee meeting on the Zilver® PTX® drug-eluting peripheral stent.2011年美国食品药品监督管理局医疗器械咨询委员会会议中关于Zilver® PTX®药物洗脱外周支架的循环系统器械小组会议概述
Cardiovasc Revasc Med. 2012 Sep-Oct;13(5):281-5. doi: 10.1016/j.carrev.2012.05.003. Epub 2012 Aug 14.
8
Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent thrombosis.2006年美国食品药品监督管理局循环系统器械小组关于药物洗脱支架血栓形成会议综述
Catheter Cardiovasc Interv. 2007 Jun 1;69(7):1064-74. doi: 10.1002/ccd.21179.
9
Concerns over safety of drug-eluting stents.对药物洗脱支架安全性的担忧。
Expert Rev Med Devices. 2006 Nov;3(6):689-90. doi: 10.1586/17434440.3.6.689.
10
Off-label use of drug-eluting stents putting it in perspective.药物洗脱支架的非标签使用：正确看待这一问题
J Am Coll Cardiol. 2008 Feb 12;51(6):615-7. doi: 10.1016/j.jacc.2007.10.028.
Zotero 插件